http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016152965-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10 |
| filingDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2016152965-A1 |
| titleOfInvention | Hypoalbuminemia improver |
| abstract | An object of the present invention is to provide an agent for improving hypoalbuminemia that is highly safe and can be administered orally. The present invention provides a hypoalbuminemia ameliorating agent comprising, as an active ingredient, a compound having a morphinan skeleton represented by the following compound or a pharmacologically acceptable acid addition salt thereof. |
| priorityDate | 2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.